VJTbio
Haidian, Beijing, China
About VJTbio
Weijiexin focuses on the high-end animal protein pharmaceutical market. It is a biopharmaceutical business that combines R&D, medicine production, and sales for cutting-edge treatments for animal health.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Funding stage: Late Stage Venture
- Last round: Series C (Jan 2024)
- Website: vjtbio.com
- Phone: +86 10-8289-6090
Industries & Categories
Biopharma, Biotechnology, Manufacturing, Pharmaceutical, Veterinary
Canonical: https://fsome.com/organization/vjtbio-2497815 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.